Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis.

@article{Iles2003EconomicEO,
  title={Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis.},
  author={Richard Iles and Julia Legh-Smith and Michael Drummond and Andrew K. Prevost and Sarah L. Vowler},
  journal={Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
  year={2003},
  volume={2 3},
  pages={120-8}
}
BACKGROUND The cost effectiveness of inhaled TOBIR tobramycin nebuliser solution (TNS) in CF and chronic pulmonary Pseudomonas aeruginosa infection has been shown in US but not in European studies. METHODS An economic evaluation of TNS was undertaken in children and adults. Lung function and resource utilisation were recorded for 24 months before and… CONTINUE READING